A Prospective, Double-blind, Randomised Controlled Trial of the Angiotensin Converting Enzyme Inhibitor Ramipril In Asymptomatic Aortic Stenosis (RIAS trial): Trial Protocol

Aortic Stenosis ◽

Enzyme Inhibitor ◽

Controlled Trial ◽

Trial Protocol ◽

Converting Enzyme ◽

Double Blind ◽

A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial)

European Heart Journal - Cardiovascular Imaging ◽

10.1093/ehjci/jev043 ◽

2015 ◽

Vol 16 (8) ◽

pp. 834-841 ◽

Cited By ~ 61

Author(s):

Sacha Bull ◽

Margaret Loudon ◽

Jane M. Francis ◽

Jubin Joseph ◽

Stephen Gerry ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Aortic Stenosis ◽

Enzyme Inhibitor ◽

Controlled Trial ◽

Converting Enzyme ◽

Double Blind ◽

Converting Enzyme Inhibitor ◽

Randomized Controlled

Multi-centre Randomised Controlled Trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB) withdrawal in advanced renal disease: The STOP-ACEi Trial

http://isrctn.org/> ◽

10.1186/isrctn62869767 ◽

2014 ◽

Author(s):

Marie Valente

Keyword(s):

Renal Disease ◽

Angiotensin Receptor Blocker ◽

Enzyme Inhibitor ◽

Controlled Trial ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

A randomised controlled trial of the angiotensin converting enzyme (ACE) inhibitor ramipril in asymptomatic aortic stenosis.

http://isrctn.org/> ◽

10.1186/isrctn24616095 ◽

2012 ◽

Author(s):

Saul Myerson

Keyword(s):

Aortic Stenosis ◽

Ace Inhibitor ◽

Controlled Trial ◽

Converting Enzyme ◽

Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: A multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril

Arthritis & Rheumatism ◽

10.1002/art.22965 ◽

2007 ◽

Vol 56 (11) ◽

pp. 3837-3846 ◽

Cited By ~ 90

Author(s):

A. E. Gliddon ◽

C. J. Doré ◽

C. M. Black ◽

N. McHugh ◽

R. Moots ◽

...

Keyword(s):

Enzyme Inhibitor ◽

Controlled Trial ◽

Raynaud’S Phenomenon ◽

Vascular Damage ◽

Converting Enzyme ◽

Double Blind ◽

Double Blind Placebo ◽

Converting Enzyme Inhibitor

RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(03)12229-5 ◽

2003 ◽

Vol 361 (9352) ◽

pp. 117-124 ◽

Cited By ~ 730

Author(s):

Naoyuki Nakao ◽

Ashio Yoshimura ◽

Hiroyuki Morita ◽

Masyuki Takada ◽

Tsuguo Kayano ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Controlled Trial ◽

Angiotensin Ii Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Diabetic Renal Disease ◽

Retraction—Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(09)61768-2 ◽

2009 ◽

Vol 374 (9697) ◽

pp. 1226 ◽

Cited By ~ 54

Author(s):

The Editors of The Lancet

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Controlled Trial ◽

Angiotensin Ii Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Diabetic Renal Disease ◽

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

ACC Current Journal Review ◽

10.1016/s1062-1458(03)00161-2 ◽

2003 ◽

Vol 12 (3) ◽

pp. 35

Author(s):

N. Nakao ◽

A. Yoshimura ◽

H. Morita ◽

M. Takada ◽

T. Kayano ◽

...

Keyword(s):

Angiotensin Ii ◽

Enzyme Inhibitor ◽

Controlled Trial ◽

Angiotensin Ii Receptor Blocker ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Diabetic Renal Disease ◽

Absence of potentiation of the skin response to intradermal bradykinin by a long-acting angiotensin converting enzyme inhibitor, trandolapril, at conventional antihypertensive dosage in human volunteers: a double-blind, randomized, cross-over, placebo-controlled trial.

Postgraduate Medical Journal ◽

10.1136/pgmj.68.803.742 ◽

1992 ◽

Vol 68 (803) ◽

pp. 742-745 ◽

Cited By ~ 1

Author(s):

T. C. Li Kam Wa ◽

E. D. Cooke ◽

J. Beacham ◽

P. Turner

Keyword(s):

Enzyme Inhibitor ◽

Controlled Trial ◽

Converting Enzyme ◽

Double Blind ◽

Converting Enzyme Inhibitor ◽

Human Volunteers ◽

Skin Response ◽

Long Acting

P1585 Improving angiotensin-converting enzyme inhibitor use in patients hospitalised with systolic heart failure: a cluster randomised controlled trial

European Heart Journal ◽

10.1016/s0195-668x(03)94723-3 ◽

2003 ◽

Vol 24 (5) ◽

pp. 289

Author(s):

N THILLY

Keyword(s):

Heart Failure ◽

Enzyme Inhibitor ◽

Controlled Trial ◽

Systolic Heart Failure ◽

Cluster Randomised Controlled Trial ◽

Converting Enzyme ◽

Cluster Randomised ◽

Double-Blind Comparison of Losartan, Lisinopril, and Metolazone in Elderly Hypertensive Patients with Previous Angiotensin-Converting Enzyme Inhibitor-Induced Cough

The Journal of Clinical Pharmacology ◽

10.1002/j.1552-4604.1997.tb04788.x ◽

1997 ◽

Vol 37 (3) ◽

pp. 253-257 ◽

Cited By ~ 32

Author(s):

Paul Chan ◽

Brian Tomlinson ◽

Tsuei-Yuen Huang ◽

Jiing-Tang Ko ◽

Tz-Shing Lin ◽

...

Keyword(s):

Enzyme Inhibitor ◽

Converting Enzyme ◽

Double Blind ◽

Hypertensive Patients ◽

Converting Enzyme Inhibitor ◽

Elderly Hypertensive ◽

Elderly Hypertensive Patients ◽

Blind Comparison